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Background: In patients with ulcerative colitis (UC), the repeated cycle of injury and repair of intestinal mucosa 
has been reported to increase the risk of colon cancer. So, a safe and efficient therapy is required for the 
treatment and prophylaxis for the disease.This study aims to investigate the efficacy of Calendula officinalis 
extract in treatment of experimentally induced ulcerative colitis in dog animal model.  
 
Methods: During fall 2010, 10 out-bred female German dogs (1-2 years old; weighs of 20-25 kg) were enrolled. 
Ulcerative colitis was induced with 6% acetic acid as enema and method of treatment was retrograde (via ene-
ma) too by C. officinalis.  
 
Results: Loose stools, diarrhea, gross bleeding and loss of body weight happened after administration of acetic 
acid and crypt damage, loss of epithelium, infiltration of inflammatory cells and depletion of goblet cells were 
noticed histologically. C. officinalis could successfully resolve the damages of UC.  
 
Conclusion: Treatment with C. officinalis can broaden the current therapy options for UC. 
 





Inflammatory bowel diseases (IBD) are chronic fluctu-
ating inflammatory diseases with unknown clear caus-
es; believed to be multifactorial and challenging in 
management of the disease. IBD has divided into two 
major group including Ulcerative colitis (UC) that in-
volves the mucosa of the rectum and colon and Crohn's 
disease (CD). Patients with UC complain from bloody 
diarrhea, abdominal pain, weight loss, chronic pain, 
side effect of drug management and especially in long 
term, colon cancer related signs. UC is idiopathic, 
chronic, relapsing and its inflammatory condition is 
immunologically mediated in the lining of the rectum 
and colon. In adults, UC is most commonly diagnosed 
between the third and fourth decades of life, with no 
difference between males and females.
1 
A decrease in antioxidant defense against increasing 
oxidative materials have been revealed in colonic muco-
sal biopsies of patients with UC.
2 The therapeutic strate-
gy for UC has focused on anti-inflammatory agents.
3 
Glucocoticoids and salicylates as well as biological 
agents against tumor necrosis factor-α (TNF-α) were 
used in treatments of UC.
4 Corticosteroids as another 
therapeutic measure are potent inhibitors of T-cell acti-
vation and pro-inflammatory cytokines,
5 while fewer 
side effects were shown for steroids used via enema 
compared to a systemic use.
6  
Calendula officinalis L. known as calendula is a 
flower from the Asteraceae family has several medi-
cal properties including bactericidal, antiseptic, anti-
inflammatory and analgesic entities.
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pollen contain triterpenoid esters (an anti-inflammatory 
property) and the carotenoids flavoxanthin and auroxan-
thin (an antioxidant property and the source of its yel-
low-orange coloration).
8 The leaves and stems contain 
other carotenoids, mostly lutein (80%) and zeaxanthin 
(5%), and beta-carotene and its extract contains sapo-
nins, resins and essential  oils
7,9 that enhance the level of 
endogenous anti-oxidant catalases,  elismutases and glu-
tathione having anti-oxidant effects.
10 C. officinalis has 
been successfully used for preventing UV-induced oxi-
dative stresses,
11 melanoma metastasis control,
12 im-




Several studies have used herbal extracts for treat-
ment of IBD.
14,15 In this regards, Medhi et al. demon-
strated that Manuka honey has synergic effects with 
sulfasalazine in enhancing antioxidant defense system 
in experimentally induced UC model in rats.
14 Souza et 
al. showed that enemas of budesonide and probiotics 
enhance the mucosal trophism in experimental colitis 
in rats.
16 According to anti-inflammatory entities of C. 
officinalis  and lack of data regarding its efficacy in 
treatment of UC, this study was performed to investi-
gate the efficacy of C. officinalis extract in treatment of 
experimentally induced UC in a dog model. 
 
 
Materials and Methods 
 
In this experimental study being performed during 
fall 2010 in Laboratory Animal Center of Shiraz Uni-
versity of Medical Sciences, 10 out-bred female 
German dogs (1-2 years old; weighs of 20-25 kg) 
were enrolled. All dogs were housed individually and 
fed standard food throughout the experiment. The 
dogs were initially evaluated for any illness by physi-
cal examination and laboratory screening. All exper-
iments were carried out under aseptic conditions and 
the protocol of anesthesia; surgical procedures, post-
operative care and sacrifice were identical for all ani-
mals. The study was approved by the Ethics Commit-
tee of Shiraz University of Medical Sciences (registra-
tion number: 90-5077). Study animals were handled in 
conformity with guidelines for the care and handling of 
laboratory animals provided by Shiraz Laboratory An-
imals Center. The dogs were randomly allocated to two 
study groups (5 in each group) to receive C. officinalis 
extract or saline enema as treatment. A 40% C. offici-
nalis solusion was prepared by Pharmacology Depart-
ment of Shiraz University of Medical Sciences.  
Ulcerative colitis was induced in all the dogs. For 
this purpose animals were kept NPO for two days and 
bowel preparation was performed for all of them on the 
day of induction. Bowel preparation was done using 30 
ml of Senagraph syrup (Sina Daru, Tehran, Iran) 
through a nasogastric tube. To check for presence of 
ulcers in the colon, 0.1 mg/kg of acepromazine was ad-
ministered. Only water was given ad libitum to animals 
during these two days. Ulcerative colitis was induced by 
acetic acid 6% (6 mg/kg/stat) enema through rectal tube. 
After 7 days of enema, the colon was evaluated by 
a rigid rectosigmoidoscope to evaluate any presence 
of any gross mucosal ulcer as described by Morris et 
al. (1994)
17 (Table 1). Multiple biopsies were provid-
ed from mucosa in 10, 20 and 30 cm proximal to the 
anal verge and transferred into the formalin for histo-
logical studies (H&E staining) as described by 
Mehrabani  et al. (2009)
18 (Table 2). In histological 
study, the samples were examined at x10 and x20 
magnification for presence or absence of ulcer, muco-
sal cell depletion, inflammatory cysts, congestion, 
mucosal atrophy, submucosal edema, inflammatory 
cells, vascular dilatation, etc. At magnification of 
x40, a histological scoring was made from 20 random 
fields per section from each specimen (Table 3). After 
histological confirmation of induction of UC in all 
animals, they were randomly divided into two groups. 
Group A received C. officinalis extract via enema 
(40% solution, 3 mL/day until 30 days) and Group B 
that received a saline enema (3 mL/day). 
Table 1: Criteria for scoring of macroscopic damage
a.
Score       Macroscopic morphology    
0               No damage 
1               Localized hyperemia, but no ulcer 
2               Linear ulcers with no significant inflammation 
3               Linear ulcer with inflammation at one site 
4               Two or more sites of ulceration and/or inflammation 
5               Two or more major sites of inflammation and ulceration or one major site     
                  inflammation and ulceration extending 41 cm along the length of the colon 
a An Inflammation was defined as regions of hyperemia and bowel wall thickening. Mehrabani et al. 
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An identical rigid rectosigmoidoscopy was repeat-
ed after 14 and 30 days of UC induction to provide 
multiple biopsies from the mucosa for histological 
study. After 45 days, another rigid rectosigmoidosco-
py was performed to take biopsies for histological 
evaluation. According to the criteria described by 
Dundar et al. (2008) for severity of colitis, all dogs 
were scored.
19 For histological study, the animals 
were sacrificed with an overdose of anesthetics. All 
statistical analyses were performed with the Statistical 
Package for Social Sciences version 16.0 (SPSS Inc., 
Chicago, Ill., USA). Chi-square test was used to com-
pare the proportions between groups. A p value of less 





In dogs received 6 ml/kg of 6% acetic acid for two 
days, typical changes related to ulcerative colitis e.g. 
Table 2: The variables used for microscopic scoring.
Variable  Severity of changes
0 1 2 3 






tions not exceeding 
the submucosa 
Ulcerations exceed-





Mild depletion in a 
few cells 
Moderate depletion 
(<50% of cells) 
Severe depletion or 
complete disappear-
ance of mucosa
Crypt abscesses  No abcesses  1–3 abscesses/ 
slide 
4–9 abscesses/slide  10 or more abscess-
es/slide 
Inflammatory cysts  No cysts  1–3 cysts/slide  4–9 cysts/slide  10 or more 
cysts/slide 

































Vascular dilatation  Normal blood 
vessels 




of several blood 
vessels 
Severe dilatation of 
several blood vessels 
 
 
Table 3: Results of  treatment in group A.
Variable After  7  days
(Before treatment) 
After 14 days After 30 days         After 45 days
 (p=0.04)                  (p=0.005) 
  1   2   3   4   5 1 2 3 4 5 1 2 3 4 5     1  2  3  4  5
Ulceration  0   1   1   0   0  0  0  1 0  0  0  0  0 0  0     0  0  0  0  0 
Mucous cell depletion  0   1   1   2   2 0 1 0 1 1 0 1 0 0 0     0  0  0  0  0
Crypt abscess  1   1   1   1   1  0  1  1 1  1  0  0  0 0  1     0  0  0  0  0 
Inflammatory cyst  0   0   0   0   0  0  0  0 0  0  0  0  0 0  0     0  0  0  0  0 
Mucosal atrophy  1   1   1   1   1 0 0 1 1 1 0 0 0 0 0     0  0  0  0  0
Submucosal edema  1   1   1   1   1  0  0  1 1  1  0  0  0 0  1     0  0  0  0  0 
Inflammatory cell  2   2   3   2   2  1  1  2 2  2  1  1  1 1  1     0  0  0  0  0 
Vascular dilatation  2   2   2   2   2 1 2 2 2 2 1 2 2 2 1     0  0  0  0  0
   Total  7   9  10  9   9  3  5  7 8  8  2  4  3 3  4     0  0  0  0  0 
 C. officinalis in ulcerative colitis 
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multiple ulcers and diffuse inflammation were noticed 
with a score of 5. After 7 days, the biopsies revealed 
inflammatory cells in mucosa and around the crypts that 
were polymorphonuclear leukocytes and lymphocytes. 
Multiple ulcerations were also noticed indicating to 
presence of a crypt abscess. In the submucosa, multifo-
cal areas of inflammation and ulceration were present 
and it was diffusely edematous. Infiltration of polymor-
phonuclear leukocytes, eosinophils and lymphocytes 
was extensive. Figure 1 demonstrates a severe inflam-
mation, PMN infiltration in lamina propria, glandular 
destruction and goblet cell depletion denoting to UC 
after 7 days (x400, H&E); Figure 2 shows a mild PMN 
infiltration and goblet cell depletion after 30 days (x100, 
H&E) and Figure 3 denotes to a complete healing after 
45 days (x400, H&E).  
 
 
Fig. 1: Severe inflammation, PMN infiltration in lami-
na propria, glandular destruction and goblet cell de-
pletion denoting to UC after 7 days (x400, H&E). 
 
 
Fig. 2: Mild PMN infiltration and goblet cell depletion 
after 30 days (x100, H&E). 
 
Fig. 3: Complete healing after 45 days of treatment 
(x400, H&E). 
 
Table 3 shows the findings of retrograde treatment 
by C. officinalis in dogs. On day 7
th, the scoring was 
7-10, on day 14
th was 3-8, on day 30




th ( p>0.05), 30
th ( p=0.04) and 45
th 
(p=0.005), the mucosal healing was statistically sig-
nificant compared to the 7
th and 14





Many reports showed that hamsters, mice or rats as 
experimental models of UC.
20-23 Administration of 
6% acetic acid into the colon led to a fast develop-
ment of severe inflammation and ulceration of the 
colon together with diarrhea, hematochezia and 
weight loss that are identical to what occurs in human 
UC. In this study, macroscopic findings were ulcera-
tion and hemorrhage. Microscopic findings were an 
increase in infiltration of polymorphonuclear leuko-
cytes, lymphocyte and presence of cryptic abscesses 
similar to human UC. 
Regarding UC induction, there are several reports 
on different chemicals to induce experimental colitis 
such as acetic acid, 2,4,6-trinitrobenzene sulfonic acid, 
dextran sodium sulfate, oxazolone and indomethacin.
24 
In this study, 6% acetic acid was used for induction of 
UC. It is easily available and an inexpensive chemical 
agent. Our findings confirmed induction of UC 
sigmoidoscopically and histologically.  
Many methods of treatment of UC are used in 
experimental animal models such as corticosteroids, 
salazosulfapyridine, azathioprine, mesalazine, 
methotrexate, 6-mercaptopurine, and cyclosporin.
25 Mehrabani et al. 
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They are mostly targeted to reduce symptoms of UC. 
However clinically, the therapeutic measure that can 
prevent a relapse may also be as important as a 
treatment to decrease symptoms.
26 They demonstrated 
that fibratide decreased the severity of experimental 
dextran sulfate sodium (DSS)-induced UC in mice 
and reported that it can be potentially beneficial in 
treatment of inflammatory bowel diseases (IBD). 
Topical use of GM-CSF on mucositis reduced the 
duration of healing time via suppressing 
inflammatory reaction and proliferating epithelia.
20 
Tozaki et al. showed that chitosan capsules were useful 
carriers in colon-specific delivery of anti-inflammatory 
drugs such as 5-ASA and the healing of TNBS-
induced colitis in rats.
27 Treatment with ECP antibody 
was shown to improve DSS-induced colitis in rats, 
probably because of increased regenerative activity of 
the colonic epithelium and downregulation of the 
immune response. Therefore, anti-ECP may promote 
intestinal wound healing in patients with UC.
23  
The colonic mucosal layer was shown as a potential 
therapeutic target for IBD based on the histological 
findings that in IBD patients, a thinner mucosal layer 
and depletion of goblet cells in the colonic epithelium 
are seen.
28 The mucosal layer is mostly composed of 
mucins and acts as a physical barrier to protect the 
epithelium from agents disturbing epithelium integrity 
and may also prevent the intestinal microflora from 
triggering abnormal immune responses.
28 They 
Showed that in mice with disrupted mucus synthesis 
suffered from more serious colitis, presence of mucus 
is important in inflammation.
28 An injury in the 
gastrointestinal tissue is usually associated with 
healing needing the production of granulation tissue 
including deposition of connective tissue matrix, 
proliferations of fibroblasts and angiogenesis for 
reconstruction of mucosal microvessels that are critical 
for delivery of oxygen and nutrients to the healing 
site.
28 In last step of healing, re-epithelialization and 
reconstruction of epithelial structures occurs.
29  
After development of injury in the mucosal layer, 
the intestinal epithelium would reestablish fast its 
integrity. To reestablish the integrity of the mucosal 
layer, epithelial cells migrate into the wounded area 
(epithelial restitution) and would later proliferate to 
replace the decrease in the cell pool. A variety of 
soluble peptides, growth factors, prostaglandins and 
cytokines are also secreted in a coordinated fashion in 
the injured area to restore mucosal integrity.
30  
Calendula officinalis is a herb having medicinal 
properties containing biologically active complex 
substances of Carotin (Provitamin A), Stearin, Triter-
piniod, Plavonoid, Kumarin, macro and micro com-
pound elements.
31 There are several reports on differ-
ent properties of Calendula officinalis L. showing that 
this herbal is effective in protection against subacute 
ciggaret smoking-induced cell injury,
32 has antimeta-
static effects,
33 antiparasitic and antibacterial effica-
cies,
34,35 spasmolytic properties,
36 wound healing and 
anti-inflammatory properties,
37,38 hepato- and reno- 
protective action,
39 and Angiogenic activity.
14 There 
are no data available on anti ulcer effect of this herbal 
in IBDs. Our findings denote to a significant mucosal 
healing after administration of C. officinalis after 30 
and 45 days.  
We showed that our therapy could well resolve the 
damages. So C. officinalis may provide an 
opportunity for UC therapy and broaden the current 
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